SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000318306-02-000003
Filing Date
2002-04-02
Accepted
2002-04-02 00:00:00
Documents
5
Period of Report
2001-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K r10k-001.txt 10-K 217510
3 STOCK PLAN AMENDMENT r10k-003.txt EX-10.25 1169
4 SUBSIDIARIES r10k-004.txt EX-21 266
5 CONSENT r10k-005.txt EX-23.1 742
6 LEASE AMENDMENT r10k-002.txt EX-10.24 4670
  Complete submission text file 0000318306-02-000003.txt   226476
Mailing Address 2600 N STEMMONS FRWY STE 176 DALLAS TX 75207
Business Address 2600 N STEMMONS FRWY STE 176 DALLAS TX 75207 2149055100
ACCESS PHARMACEUTICALS INC (Filer) CIK: 0000318306 (see all company filings)

IRS No.: 830221517 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-15771 | Film No.: 02598778
SIC: 2834 Pharmaceutical Preparations